Nasdaq: OPTH Manufacturing Commercial-Stage Psychedelic Medicines to Treat Serious Mental Health Conditions Optimi Health Corp. (Nasdaq: OPTH) is a commercial-stage psychedelic drug manufacturer producing finished-dose psilocybin and MDMA capsules for authorized clinics, pharmacies, and clinical trial sponsors around the world. Chart Website LATEST NEWS Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted… Continue reading OPTH
Month:
SURG
Nasdaq: SURG Bridging Connectivity and Financial Services for Underserved Communities SurgePays, Inc. (Nasdaq: SURG) is a technology-driven wireless and fintech company bridging connectivity and financial service gaps in underserved and subprime communities through a network of more than 9,000 retail partners offering wireless, prepaid, and point-of-sale services. Chart Website LATEST NEWS SurgePays Reports Q2 2026… Continue reading SURG